Compare PAHC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | INSP |
|---|---|---|
| Founded | 1946 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2014 | 2018 |
| Metric | PAHC | INSP |
|---|---|---|
| Price | $32.07 | $51.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $41.25 | ★ $94.00 |
| AVG Volume (30 Days) | 250.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 1883.33 | 179.43 |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $833,350,000.00 | $82,050,000.00 |
| Revenue This Year | $17.03 | $8.02 |
| Revenue Next Year | $3.82 | $8.11 |
| P/E Ratio | $17.04 | ★ N/A |
| Revenue Growth | 4.12 | ★ 62.18 |
| 52 Week Low | $25.58 | $38.91 |
| 52 Week High | $60.08 | $147.03 |
| Indicator | PAHC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 72.13 |
| Support Level | $30.46 | $48.30 |
| Resistance Level | $34.49 | $58.45 |
| Average True Range (ATR) | 1.22 | 2.22 |
| MACD | 0.46 | 1.06 |
| Stochastic Oscillator | 40.30 | 97.48 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.